Regina El Dib

Regina El Dib

Auto-generated profile, based on publicly available information

Regina El Dib

Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, Universidade Estadual Paulista, São José Dos Campos, SP, Brazil; McMaster Institute of Urology, McMaster University, St. Joseph's Healthcare, Hamilton, ON, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
RDRegina El Dib
Regina El Dib
APAravind Gandhi P
Aravind Gandhi P
JBJessica Lima de Barros
Jessica Lima de Barros
CFCarolina Gonzales França
Carolina Gonzales França
FSFernanda Labiapari Senefonte
Fernanda Labiapari Senefonte
Anil KapoorAnil Kapoor
Anil Kapoor

1 December 2020 in Archives of Oral Biology
Verified
Journal Article
Closed access
RZRayssa Ferreira Zanatta
Rayssa Ferreira Zanatta
TCTaciana Caneppele
Taciana Caneppele
TSTais Scaramucci
Tais Scaramucci
RDRegina El Dib
Regina El Dib
LMLucianne Cople Maia
Lucianne Cople Maia
Alexandre BorgesAlexandre Borges
Alexandre Borges

9 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJosé Eduardo Guimarães Pereira
José Eduardo Guimarães Pereira
RDRegina El Dib
Regina El Dib
LBLeandro G. Braz
Leandro G. Braz
JEJanaina Escudero
Janaina Escudero
JHJason Hayes
Jason Hayes
BJBradley C. Johnston
Bradley C. Johnston
Cardiac surgeries are complex procedures aiming to re-establish coronary flow and correct valvular defects. Oxidative stress, caused by inflammation and ischemia-reperfusion injury, is associated with these procedures, increasing the risk of adverse outcomes. N-acetylcysteine (NAC) acts as an antioxidant by replenishing the glutathione stores, and emerging evidence suggests that NAC may reduce the risk of adverse perioperative outcomes. We conducted a systematic review and meta-analysis to investigate the addition of NAC to a standard of care among adult patients undergoing cardiac surgery. We searched four databases (PubMed, EMBASE, CENTRAL, LILACS) from inception to October 2018 and the grey literaure for randomized controlled trials (RCTs) investigating the effect of NAC on pre-defined outcomes including mortality, acute renal insufficiency (ARI), acute cardiac insufficiency (ACI), hospital length of stay (HLoS), intensive care unit length of stay (ICULoS), arrhythmia and acute myocardial infarction (AMI). Reviewers independently screened potentially eligible articles, extracted data and assessed the risk of bias among eligible articles. We used the GRADE approach to rate the overall certainty of evidence for each outcome. Twenty-nine RCTs including 2,486 participants proved eligible. Low to moderate certainty evidence demonstrated that the addition of NAC resulted in a non-statistically significant reduction in mortality (Risk Ratio (RR) 0.71; 95% Confidence Interval (CI) 0.40 to 1.25), ARI (RR 0.92; 95% CI 0.79 to 1.09), ACI (RR 0.77; 95% CI 0.44 to 1.38), HLoS (Mean Difference (MD) 0.21; 95% CI -0.64 to 0.23), ICULoS (MD -0.04; 95% CI -0.29 to 0.20), arrhythmia (RR 0.79; 95% CI 0.52 to 1.20), and AMI (RR 0.84; 95% CI 0.48 to 1.48). Among eligible trials, we observed heterogeneity in the population and interventions including patients with and without kidney dysfunction and interventions that differed in route of administration, dosage, and duration of treatment. This observed heterogeneity was not explained by our subgroup analyses. The addition of NAC during cardiac surgery did not result in a statistically significant reduction in clinical outcomes. A large randomized placebo-controlled multi-centre trial is needed to determine whether NAC reduces mortality. PROSPERO CRD42018091191.

16 February 2021 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
JRJoao Vitor da Silva Rodrigues
Joao Vitor da Silva Rodrigues
JPJosé E. Guimarães Pereira
José E. Guimarães Pereira
LPLuisa Almeida Passarelli
Luisa Almeida Passarelli
GGGabrielle M.G.B. Guatura
Gabrielle M.G.B. Guatura
RDRegina El Dib
Regina El Dib
BACKGROUND: Previous studies have suggested that healthcare professionals may be susceptible to substance use disorders, and among the medical specialties, anaesthesia providers appear to be overrepresented. OBJECTIVE: We aimed to compare the prevalence of substance use-related mortality and suicides between anaesthesia and nonanaesthesia professionals. DESIGN: Systematic review of observational studies with meta-analyses. We defined anaesthesia providers as any healthcare professionals belonging to the specialty, regardless of age and duration of employment. Other healthcare professionals served as the control group. DATA SOURCES: Ovid Medline, EMBASE, Web of Science, Scopus, Scielo, LILACS and ProQuest databases up to March 2020. RESULTS: Thirty-nine studies were included, 31 cross-sectional studies involving 13 819 participants and eight cohorts with a total 129 811 participants proved eligible. Results suggested a higher rate of drug-related mortality with odds ratio (OR) 2.69 [95% confidence interval (CI), 1.80 to 4.00; P < 0.001; I 2 = 0%, P = 0.55; high-certainty evidence] and suicide (OR 2.18, 95% CI, 1.33 to 3.58; P = 0.002; I 2 = 0%, P = 0.68; moderate-certainty evidence) for anaesthesia providers compared with other healthcare professionals. CONCLUSION: High-to-moderate-certainty evidence shows that there is more than a two-fold increased rate of substance use-related mortality and suicide among anaesthesia providers compared with other healthcare professionals. Investigations examining substance abuse between healthcare professionals, with particular attention to working conditions and exposure are essential to further develop preventive strategies.